Breaking News

ICON Appoints Analytics and Consulting VP

September 3, 2014

Spector brings 25 years of experience

Dr. Ira Spector has been appointed executive vice president, Analytics and Consulting, ICON plc. Dr. Spector will lead ICON’s global consulting and drug development services and will be responsible for business process improvement and analytics capabilities.
Dr. Spector has more than 25 years of experience in managing global drug and medical device development programs. He joins the company from Allergan Pharmaceuticals, where he was senior vice president of Global Development Operations, responsible for 11 global research centers, which contributed to approvals in more than 51 countries.
Dr. Spector previously spent 17 years at Wyeth Research, most recently as vice president, Global Development Operations and vice chief of Development, responsible for global clinical trial management.
Dr. Steve Cutler, chief operating officer at ICON, said, “I would like to welcome Dr. Spector to the ICON team. His extensive experience in managing some of the world’s largest trials in areas such as oncology, vaccines and CNS, coupled with his expertise in using technology to drive innovation and process improvement, will enable us to provide further strategic input to our customers’ drug and device programs.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.